You have 9 free searches left this month | for more free features.

Condition

Type 2 Diabetes Mellitus (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Sanofi (1)

Collaborator

Hanmi Pharmaceutical Company Limited (1)

Intervention

background therapy metformin (1)

dulaglutide (1)

efpeglenatide (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

efpeglenatide

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Type 2 Diabetes Trial in Worldwide (Efpeglenatide, Dulaglutide, Background therapy Metformin)

Terminated

Type 2 Diabetes Mellitus

Efpeglenatide
+2 more

Birmingham, Alabama
+44 more

Oct 28, 2021